Virinchi Limited has informed the Exchange about General Updates
VIRINCHI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Virinchi Limited's subsidiary, Virinchi Health Care Private Limited (VHPL), allotted 52,22,000 Convertible Equity Warrants to promoter Mr. Viswanath Kompella on a preferential basis at Rs. 15 per warrant on March 3, 2026. All warrants were subsequently converted into equity shares (48,85,000 on March 5 and 3,37,000 on March 9, 2026), bringing in Rs. 7.83 crore in total consideration. As a result, VHPL ceased to be a wholly-owned subsidiary, with Virinchi Limited's stake dropping from 100% to 51% and the promoter holding the remaining 49%. The enterprise valuation of VHPL was pegged at Rs. 312.08 crore by an independent valuer. The transaction was approved via postal ballot and qualifies as a related party transaction.
The dilution in Virinchi's subsidiary from 100% to 51% means the company will consolidate only 51% of VHPL's earnings going forward, though VHPL contributed 30.73% (Rs. 92.54 crore) of consolidated revenue in FY25 and has a negative net worth. The promoter's increased direct stake in the healthcare subsidiary signals a focused commitment to the healthcare business, which is positive for long-term value creation.